• Ornithine Aspartate Injection 5g/10ml
  • Ornithine Aspartate Injection 5g/10ml
  • Ornithine Aspartate Injection 5g/10ml
  • Ornithine Aspartate Injection 5g/10ml
  • Ornithine Aspartate Injection 5g/10ml

Ornithine Aspartate Injection 5g/10ml

Package: 5AMP/Box
Composition: Ornithine Aspartate
Transport Package: Free
Specification: 5g/10ml
Trademark: Sinolead
Origin: China
Samples:
US$ 0.1/Piece 1 Piece(Min.Order)
| Request Sample
Customization:
Manufacturer/Factory, Trading Company, Group Corporation
Gold Member Since 2018

Suppliers with verified business licenses

Rating: 3.0/5
Guangdong, China
to see all verified strength labels (6)

Basic Info.

Model NO.
orinithine

Product Description

Ornithine Aspartate Injection 5g/10ml
Product Dose Package
Ornithine Aspartate Injection  5g/10ml 5Amp/box
Ornithine Aspartate Injection 5g/10ml
  • Ornithine Aspartate Injection is a pharmaceutical preparation containing a combination of ornithine and aspartate. Ornithine and aspartate are amino acids that play essential roles in the urea cycle, which is involved in the detoxification of ammonia in the body, particularly in the liver.


Indications:

Ornithine Aspartate Injection is indicated for the treatment of hepatic encephalopathy, particularly in patients with liver cirrhosis or acute liver failure. It is effective in improving mental function and reducing the severity of symptoms associated with hepatic encephalopathy, such as confusion, disorientation, and altered consciousness.

Precautions:

Before administering Ornithine Aspartate Injection, healthcare providers assess the patient's medical history, including liver function tests and any known allergies. Close monitoring of patients receiving this medication is essential to ensure optimal therapeutic outcomes and to detect any adverse reactions promptly. Ornithine Aspartate Injection should be used with caution in patients with kidney impairment.

Usage Instructions:

This medication is administered intravenously (IV) under medical supervision, typically in hospital settings. The dosage and duration of treatment vary based on the severity of hepatic encephalopathy and the patient's individual response to therapy. Healthcare providers determine the appropriate dosage regimen for each patient.



Ornithine Aspartate Injection 5g/10mlOrnithine Aspartate Injection 5g/10mlOrnithine Aspartate Injection 5g/10mlOrnithine Aspartate Injection 5g/10ml

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Gold Member Since 2018

Suppliers with verified business licenses

Rating: 3.0/5
Manufacturer/Factory, Trading Company, Group Corporation
Registered Capital
1000000 RMB
Plant Area
101~500 square meters